These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19004060)

  • 1. Anti-citrullinated protein antibody response associated with synovial immune deposits in a patient with suspected early rheumatoid arthritis.
    Willemze A; Ioan-Facsinay A; El-Gabalawy H
    J Rheumatol; 2008 Nov; 35(11):2282-4. PubMed ID: 19004060
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibody determination in the synovial fluid of patients with rheumatoid arthritis: comment on the article by Caspi et al.
    Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
    Arthritis Rheum; 2006 Aug; 55(4):681-2; author reply 682. PubMed ID: 16874773
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of citrullinated proteins with synovial exosomes.
    Skriner K; Adolph K; Jungblut PR; Burmester GR
    Arthritis Rheum; 2006 Dec; 54(12):3809-14. PubMed ID: 17133577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
    Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
    Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice.
    Iwaki-Egawa S; Matsuno H; Ogawa Y; Watanabe Y
    Ann Rheum Dis; 2005 Jul; 64(7):1094-5. PubMed ID: 15958770
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
    Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
    Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

  • 10. Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion.
    Bos WH; Nielen MM; Dijkmans BA; van Schaardenburg D
    Ann Rheum Dis; 2008 Nov; 67(11):1642. PubMed ID: 18854513
    [No Abstract]   [Full Text] [Related]  

  • 11. Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers VM
    Nat Clin Pract Rheumatol; 2006 Aug; 2(8):400-1. PubMed ID: 16932728
    [No Abstract]   [Full Text] [Related]  

  • 12. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.
    Tilleman K; Van Steendam K; Cantaert T; De Keyser F; Elewaut D; Deforce D
    Rheumatology (Oxford); 2008 May; 47(5):597-604. PubMed ID: 18326534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?
    Bykerk V
    J Rheumatol; 2009 Aug; 36(8):1565-7. PubMed ID: 19671806
    [No Abstract]   [Full Text] [Related]  

  • 14. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis.
    Tamai M; Kawakami A; Uetani M; Takao S; Tanaka F; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Kamachi M; Huang M; Origuchi T; Ida H; Aoyagi K; Eguchi K
    Ann Rheum Dis; 2006 Jan; 65(1):133-4. PubMed ID: 16344500
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis.
    Spadaro A; Riccieri V
    Ann Rheum Dis; 2005 Aug; 64(8):1241-2. PubMed ID: 16014691
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
    Somers K; Stinissen P; Somers V
    Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 20. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.